Recce Pharmaceuticals is Biotechnology in Australia that focus on Recce Pharmaceuticals Ltd business. Founded in 2007. They cover business area such as Recce Pharmaceuticals Ltd, commercialization, antibiotic, research, development, pharmaceutical drug, three geographic segment, Australia, America, various bacteria, namely Sepsis, Helicobacter Pylori, Escherichia coli, Pseudomonas aeruginosa.
2007
( 17 years old in 2024 )
Recce Pharmaceuticals Ltd
-
Level 36, 1 Macquarie Place
Gateway Tower
Sydney, New South Wales 2000
Australia
Private
Recce Pharmaceuticals Ltdcommercializationantibioticresearchdevelopmentpharmaceutical drugthree geographic segmentAustraliaAmericavarious bacterianamely SepsisHelicobacter PyloriEscherichia coliPseudomonas aeruginosa
* We use standard office opening hours in near Recce Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Recce Pharmaceuticals is Biotechnology business from Australia that founded in 2007 (17 years old in 2024), Recce Pharmaceuticals business is focusing on Recce Pharmaceuticals Ltd.
Recce Pharmaceuticals headquarter office and corporate office address is located in Level 36, 1 Macquarie Place Gateway Tower Sydney, New South Wales 2000 Australia.
Recce Pharmaceuticals was founded in Australia.
In 2024, Recce Pharmaceuticals is currently focus on Recce Pharmaceuticals Ltd sector.
Above is snippet of Google Trends for "Recce Pharmaceuticals Ltd" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Recce Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
